Integration of Clinical, Genomic and Proteomic Data using a Bioinformatic Approac
使用生物信息学方法整合临床、基因组和蛋白质组数据
基本信息
- 批准号:7897734
- 负责人:
- 金额:$ 39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-22 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AlgorithmsAmino AcidsAreaArtsBioinformaticsBiologicalBiological MarkersBiological SciencesBiologyBiomedical ComputingBiomedical ResearchBuffaloesCell Culture TechniquesClinicalClinical DataClinical ManagementComplexComputational ScienceComputing MethodologiesCoupledDataData SetDatabasesDecision MakingDevelopmentDisciplineDiseaseDisease OutcomeDisease ProgressionEngineeringGene ExpressionGene ProteinsGeneticGenetic PolymorphismGenetic VariationGenomicsGoalsGrowthHIVHIV InfectionsHIV-1HLA-B27 AntigenHaplotypesHealthHumanInfectionInformaticsInformation TechnologyIntegration Host FactorsInterleukin-10Interleukin-4InternetIsotopically-Coded Affinity TaggingKnowledgeLabelLiquid ChromatographyMedicalMedical InformaticsMethodsMetricMiningMolecularMolecular BiologyMolecular TargetNIH Program AnnouncementsOnline SystemsOutcomePathogenesisPatientsPatternPeripheral Blood Mononuclear CellPhenotypePolymorphism AnalysisPredispositionProcessProteinsProteomicsPublic HealthRANTESRelative (related person)ResearchResearch Project GrantsResourcesRoleScienceScientistSingle Nucleotide PolymorphismStable Isotope LabelingTechnologyTherapeuticTimeTranslational ResearchUnited States National Institutes of HealthVirusantiretroviral therapybiomedical informaticscDNA Arrayscohortcomputer sciencecomputerized toolsdata miningdesignevidence baseflexibilitygel electrophoresisinnovationinterestmembernovelnovel markerprogramsprotein expressionreceptorrelational databaseresponsetandem mass spectrometrytooltransmission processtwo-dimensional
项目摘要
DESCRIPTION (provided by applicant):
Major developments in molecular biology, coupled with strides in genomics and proteomics, have led to an explosive growth in biological data. To obtain usable, relevant information from these vast databases (e.g. through data mining) it is mandatory to use advanced computational methods and hardware. The rapidly expanding field of bioinformatics, where biology, computer science, and information technology merge to form a single discipline, has the potential to serve as a bridge between medical informatics and experimental science. In this proposal we focus on a unique cohort of HIV-1 infected subjects, long term non-progressors (LTNP), who can remain asymptomatic for >15 yr without antiretroviral therapy. Many factors underlie the LTNP state. This project, which expands our current bioinformatics studies in a more translational direction, will develop a complex clinical and experimental database that will be analyzed by powerful informatics tools to identify key genes and proteins that contribute to the LTNP phenotype. We hypothesize that using innovative informatics technology that we specifically develop, we shall prepare a publicly available, large, interactive database containing medical, genomic and proteomic information on HIV-1 infected patients that can be queried to guide rational, evidence-based, decision making at both the clinical and public health levels. Our proposal represents a productive partnership between 3 specialized research groups, with extensive expertise in: a) clinical management of HIV-1 disease, b) molecular and cellular immunovirology, and c) bioinformatics and computational sciences. The goal of this biomedical informatics proposal is the characterization and efficient utilization of data obtained from basic biomedical research and integrate it with clinical outcome. The following specific aims are proposed. Specific Aim 1: To identify functional genes and proteins that are unique to our specific HIV-1 infected patient cohorts using state of the art genomic and proteomic technologies. Specific Aim 2: To evaluate the role of human allelic variants in influencing the rate of HIV-1 disease progression using SNP analysis and real time, quantitative PCR. Specific Aim 3: To develop new computational tools to analyze and integrate genomic, proteomic, and clinical data from our HIV-1 patient cohorts and convert them into clinically useful information relating to the pathogenesis, transmission and therapeutic response of HIV-1 infected patients. This will involve the design of: data mining-oriented schemas; advanced algorithms for integrating genomic, proteomic, and clinical data in a data warehouse; and metrics and methods to explore the association between host genetic variations and HIV disease. Ultimately this database will be provided on the web as a publicly accessible resource. This study will contribute to our fundamental understanding of the pathogenesis of HIV infections and identify new biomarkers of disease progression and potential molecular targets for therapy.
描述(由申请人提供):
分子生物学的主要发展,再加上基因组学和蛋白质组学方面的步伐,导致了生物学数据的爆炸性增长。为了从这些庞大的数据库中获取可用的相关信息(例如,通过数据挖掘)必须使用先进的计算方法和硬件。生物学,计算机科学和信息技术合并以形成单一学科的生物信息学的快速扩展领域具有作为医学信息学和实验科学之间的桥梁的潜力。在此提案中,我们着重于独特的HIV-1感染受试者,长期非培训器(LTNP),他们可以在没有抗逆转录病毒疗法的情况下无症状> 15年。 LTNP状态是许多因素。该项目将我们当前的生物信息学研究扩展到更加转化的方向,将开发一个复杂的临床和实验数据库,该数据库将通过强大的信息学工具来分析,以识别有助于LTNP表型的关键基因和蛋白质。我们假设,使用我们专门开发的创新信息学技术,我们将准备一个公开可用的,大型的交互式数据库,其中包含有关HIV-1感染患者的医学,基因组和蛋白质组学信息,这些信息可用于指导临床和公共健康水平的理性,基于证据的,循证的决策,决策。我们的建议代表了3个专业研究小组之间的富有成效的伙伴关系,其中具有广泛的专业知识:a)HIV-1疾病的临床管理,b)分子和细胞免疫病毒学,以及c)生物信息学和计算科学。该生物医学信息学建议的目的是对从基本生物医学研究获得的数据进行表征和有效利用,并将其与临床结果相结合。提出了以下特定目标。特定目的1:鉴定使用ART基因组和蛋白质组学技术的特定HIV-1感染患者同类群体所独有的功能基因和蛋白质。具体目的2:评估人类等位基因变体在使用SNP分析和实时的定量PCR来影响HIV-1疾病进展率的作用。特定目的3:开发新的计算工具来分析和整合来自HIV-1患者同伙的基因组,蛋白质组学和临床数据,并将其转换为与HIV-1感染患者的发病机理,传播和治疗反应有关的临床有用信息。这将涉及以下设计:面向数据挖掘的模式;用于在数据仓库中整合基因组,蛋白质组学和临床数据的高级算法;以及探索宿主遗传变异与艾滋病毒疾病之间关联的指标和方法。最终,该数据库将作为公共访问资源提供在网络上。这项研究将有助于我们对HIV感染的发病机理的基本理解,并确定疾病进展的新生物标志物和治疗的潜在分子靶标。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STANLEY A SCHWARTZ其他文献
STANLEY A SCHWARTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STANLEY A SCHWARTZ', 18)}}的其他基金
A Multimodal Hierarchical Theranostic Nanoparticle for Castration Resistant Prostate Cancer
用于去势抵抗性前列腺癌的多模式分级治疗诊断纳米颗粒
- 批准号:
10259187 - 财政年份:2022
- 资助金额:
$ 39万 - 项目类别:
A Multimodal Hierarchical Theranostic Nanoparticle for Castration Resistant Prostate Cancer
用于去势抵抗性前列腺癌的多模式分级治疗诊断纳米颗粒
- 批准号:
10513295 - 财政年份:2022
- 资助金额:
$ 39万 - 项目类别:
IL-8 targeted Nanotherapy for Prostate Cancer.
IL-8 靶向纳米疗法治疗前列腺癌。
- 批准号:
8507652 - 财政年份:2012
- 资助金额:
$ 39万 - 项目类别:
IL-8 targeted Nanotherapy for Prostate Cancer.
IL-8 靶向纳米疗法治疗前列腺癌。
- 批准号:
8385330 - 财政年份:2012
- 资助金额:
$ 39万 - 项目类别:
Integration of Clinical, Genomic and Proteomic Data using a Bioinformatic Approac
使用生物信息学方法整合临床、基因组和蛋白质组数据
- 批准号:
7685903 - 财政年份:2009
- 资助金额:
$ 39万 - 项目类别:
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS
糖尿病干预和并发症的流行病学
- 批准号:
7199002 - 财政年份:2004
- 资助金额:
$ 39万 - 项目类别:
Epidemiology of Diabetes Intervention and Complications
糖尿病干预和并发症的流行病学
- 批准号:
7039541 - 财政年份:2003
- 资助金额:
$ 39万 - 项目类别:
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS
糖尿病干预和并发症的流行病学
- 批准号:
6565883 - 财政年份:2001
- 资助金额:
$ 39万 - 项目类别:
相似国自然基金
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
催化不对称自由基反应合成手性α-氨基酸衍生物
- 批准号:22371216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
特定肠道菌种在氨基酸调控脂质代谢中的作用与机制研究
- 批准号:82300940
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道菌群紊乱导致支链氨基酸减少调控Th17/Treg平衡相关的肠道免疫炎症在帕金森病中的作用和机制研究
- 批准号:82301621
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
氨基酸调控KDM4A蛋白N-末端乙酰化修饰机制在胃癌化疗敏感性中的作用研究
- 批准号:82373354
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:
10597840 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
量化血浆中的蛋白质确实使 1 型糖尿病患者的个性化医疗民主化
- 批准号:
10730284 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Exploiting translation elongation for improved biologics manufacturing
利用平移伸长来改进生物制品的制造
- 批准号:
10760927 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Integrative deep learning algorithms for understanding protein sequence-structure-function relationships: representation, prediction, and discovery
用于理解蛋白质序列-结构-功能关系的集成深度学习算法:表示、预测和发现
- 批准号:
10712082 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Next generation implicit solvation for atomistic modeling
用于原子建模的下一代隐式溶剂化
- 批准号:
10344019 - 财政年份:2022
- 资助金额:
$ 39万 - 项目类别: